Orchid Pharma Obtains Trading Approval for 4.46 Crore Amalgamation Shares
Orchid Pharma Ltd 路 Others (Uncategorized) 路 24 Sept 2026, 1:30 am
Orchid Pharma Obtains Trading Approval for 4.46 Crore Amalgamation Shares Orchid Pharma Limited received trading approval from the NSE and BSE for 4,45,86,052 equity shares, effective 23rd Sep'26. These shares were previously allotted on 1st Aug'26 pursuant to an NCLT Chennai-approved Scheme of Amalgamation. With listing and trading formalities completed across both exchanges, the newly allotted shares are now fully admitted to dealings, expanding the company's freely tradable equity base.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
